Blood Journal
Leading the way in experimental and clinical research in hematology

Deciphering the molecular and biological processes that mediate histone deacetylase inhibitor-induced thrombocytopenia

  1. Mark J Bishton1,
  2. Simon J Harrison2,
  3. Benjamin P Martin1,
  4. Nicole McLaughlin1,
  5. Chloé James3,
  6. Emma C Josefsson3,
  7. Katya J Henley3,
  8. Benjamin T Kile4,
  9. H. Miles Prince2, and
  10. Ricky W Johnstone1,*
  1. 1 Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
  2. 2 Haematology Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
  3. 3 Molecular Medicine Division, The Walter and Eliza Hall Institute, Parkville, VIC, Australia;
  4. 4 University of Melbourne, Parkville, VIC, Australia
  1. * Corresponding author; email: ricky.johnstone{at}petermac.org
This article has an Erratum 125(24):3824

To view this item, select one of the options below

If you already have a subscription, you may gain access using your ASH username and password.

Sign In for Institutional Administrators

If you are a Librarian or institutional account administrator you can use this link to manage your account and view usage reports.

 

Purchase Short-Term Access

Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00.
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

OpenAthens Users

Log in through your institution

Sign Up

Subscribe to the Journal - Subscribe to the print and/or online journal.

Access for Patients

Access for Patients - Patients desiring access should contact the journal.